Results 211 to 220 of about 31,601 (273)

P1107 Biosimilar but not quite the same?: Post-induction levels of infliximab differ between brands [PDF]

Prashant Patel, M Love, Peter J. Rimmer, Rachel Cooney, Karl Hazel   +4 more
openalex   +1 more source

Comparative efficacy of intravitreal aflibercept biosimilar QL1207 versus reference aflibercept in the treatment of diabetic macular edema. [PDF]

Front Med (Lausanne)
Zhai G, Liu N, Wang S, Zhang X.
europepmc   +1 more source

Efficacy & safety of adalimumab biosimilar in axial spondyloarthritis: A retrospective study from a tertiary care centre in South India. [PDF]

Indian J Med Res
Gopalan A, Gavali M, Yerram K.
europepmc   +1 more source

Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework. [PDF]

Rheumatol Int
Cheng V, Amiri N, Cheng V, Ellis U, Cragg JJ, Proulx L, Tucker DR, De Vera MA.   +7 more
europepmc   +1 more source

Biosimilar [PDF]

, 2020
openaire   +1 more source

Using machine learning algorithms to optimize treatment with high-cost biologics in a national cohort of patients with inflammatory bowel disease. [PDF]

JAMIA Open
Hou JK, Tang TM, Sansgiry S, Van T, Richardson PA, Pham C, Cunningham F, Baker JA, Zhu J, Waljee AK.   +9 more
europepmc   +1 more source

Biologic Drug Prices in Medicare Part B After Entry of Biosimilars to the Market.

JAMA Netw Open
Abdelaziz A, Winn AN, Dusetzina SB, Mitchell AP.   +3 more
europepmc   +1 more source

CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial. [PDF]

BMJ Open
Dai R, Zhang P, Cheng M, Bi F, Zhou J, Liu M.   +5 more
europepmc   +1 more source

Short-Term Effects of Intravitreal Ranibizumab Biosimilar Injections in Patients with Neovascular Age-Related Macular Degeneration on Retinal Nerve Fiber Layer Thickness. [PDF]

J Clin Med
Lee SY, Hwang DD.
europepmc   +1 more source

Efficacy and safety of transarterial chemoembolization combined with sintilimab and bevacizumab in hepatocellular carcinoma. [PDF]

Front Oncol
Wu Y, Yu M, Zhou T, Tian Y, Song Y.
europepmc   +1 more source